Tempest Therapeutics, Inc. (TPST)

1.06 -1.85% (-0.02)

Over 1M: +23.8%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

1 1.2
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q4 '15 — Revenue: 157K Q1 '16 — Revenue: 146K Q2 '16 — Revenue: 189K Q3 '16 — Revenue: 197K Q4 '16 — Revenue: 121K Q1 '17 — Revenue: 63K Q2 '17 — Revenue: 84K Q3 '17 — Revenue: 56K Q4 '17 — Revenue: 91K Q1 '18 — Revenue: 67K Q2 '18 — Revenue: 81K Q3 '18 — Revenue: 55K 0 40K 80K 120K 160K 200K
Q1 '16 Q3 '16 Q1 '17 Q3 '17 Q1 '18 Q3 '18
Revenue

Figures as at 2018-09-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

10.0
Asset turnover 0.021×
Gross margin -110.8%
ROCE -581.9%
Accruals —
Capex / sales —
EBITDA margin —
FCF margin —
OCF / EBIT —
OCF margin —
OE margin —
Oper. margin —
Profit margin —
ROA —
ROE —
ROIC —

1 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

1 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

5.0
ND/EBITDA —
Current ratio 0.38×
Debt payback 0.0 yr
Quick ratio 0.38×
Cash / Debt —
Cash runway —
Debt / Eq —
Equity / Assets —
F-score —
Interest cover —
Payout —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.4
Sales/sh Y/Y -0.49%
Sales Q/Q +6.3%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —
Shares change —

2 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.